Citation Impact
Citing Papers
Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives
2009
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
2019 Standout
MutL traps MutS at a DNA mismatch
2015 StandoutNobel
Origins and Prevalence of the American Founder Mutation of MSH2
2008
Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment
2007
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Elevated HIV Prevalence Despite Lower Rates of Sexual Risk Behaviors Among Black Men in the District of Columbia Who Have Sex with Men
2010
Sexual mixing and the risk environment of sexually active transgender women: data from a respondent-driven sampling study of HIV risk among transwomen in San Francisco, 2010
2014
Immunohistochemistry versus Microsatellite Instability Testing For Screening Colorectal Cancer Patients at Risk For Hereditary Nonpolyposis Colorectal Cancer Syndrome
2008
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
New Developments in Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) and Mismatch Repair Gene Testing
2006
Immunohistochemistry as First-line Screening for Detecting Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome
2009
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
2012
Shedding light onto live molecular targets
2003 Standout
Microsatellite instability in colorectal cancer—the stable evidence
2010
Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification
2012
Base-excision repair of oxidative DNA damage
2007 StandoutNature
Hepatocellular carcinoma
2003 Standout
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications
2006
Frequency of Hereditary Non-Polyposis Colorectal Cancer among Unselected Patients with Colorectal Cancer in Germany
2006
CD44: From adhesion molecules to signalling regulators
2003 Standout
Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer
2007
Microsatellite Instability in Colorectal Cancer
2010 Standout
Global health burden and needs of transgender populations: a review
2016 Standout
Hepatocellular carcinoma
2018 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Biocompatibility of mannuronic acid-rich alginates
1997
Ovarian cancer
2014 Standout
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
A Novel Approach to Prevention for At-Risk HIV-Negative Men Who Have Sex With Men: Creating a Teachable Moment to Promote Informed Sexual Decision-Making
2011
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
2008
Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis
2009
Cushing's syndrome
2015 Standout
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
2010
Autocrine secretion of TGF-β1 and TGF-β2 by pre-adipocytes and adipocytes: A potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells
1998
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Hepatocellular carcinoma
2012 Standout
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
1996 Standout
Microsatellite instability: an update
2015
Colorectal cancer
2013 Standout
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
2015 Standout
MutS switches between two fundamentally distinct clamps during mismatch repair
2011
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
2009
The strawberry: Composition, nutritional quality, and impact on human health
2011 Standout
Colorectal cancer
2019 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
1997
Peritoneal Carcinomatosis of Colorectal Origin
2006
Ulcerative colitis
2012 Standout
Clinical Performance of Original and Revised Bethesda Guidelines for the Identification of MSH2/MLH1 Gene Carriers in Patients with Newly Diagnosed Colorectal Cancer: Proposal of a New and Simpler Set of Recommendations
2006
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
2008
Advances in FDG PET Probes in Surgical Oncology
2002
Safety and advantages of laparoscopic vs. open colectomy in the elderly
2000
Prediction of MLH1 and MSH2 Mutations in Lynch Syndrome
2006
Carcinoses péritonéales traitées par chirurgie de réduction tumorale et chimiohyperthermie intrapéritonéale
2000
Lower Gastrointestinal Tract Cancer Predisposition Syndromes
2010
Milestones of Lynch syndrome: 1895–2015
2015
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome
2009
Genetics, Inheritance and Strategies for Prevention in Populations at High Risk of Colorectal Cancer (CRC)
2012
TGFβ in Cancer
2008 Standout
Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies
1995
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial
2010
CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration
2000
Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: Effect of estrogen and progesterone
1992
Differential Features of Colorectal Cancers Fulfilling Amsterdam Criteria without Involvement of the Mutator Pathway
2005
Microenvironmental regulation of metastasis
2008 Standout
Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer)*
2007
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
2000
Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial
2002 Standout
Hereditary and Familial Colon Cancer
2010
Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis
2000
Adipocyte differentiation from the inside out
2006 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Report From the Jerusalem Workshop on Lynch Syndrome-Hereditary Nonpolyposis Colorectal Cancer
2010
Identification and Survival of Carriers of Mutations in DNA Mismatch-Repair Genes in Colon Cancer
2006
Factors Predicting Survival After Intraperitoneal Hyperthermic Chemotherapy With Mitomycin C After Cytoreductive Surgery for Patients With Peritoneal Carcinomatosis
2003
Most Patients with Colorectal Tumors at Young Age Do Not Visit a Cancer Genetics Clinic
2008
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
2009
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter
2006
Cyanine Fluorochrome-Labeled Antibodies in Vivo: Assessment of Tumor Imaging Using Cy3, Cy5, Cy5.5, and Cy7
1998
Epigenetic mechanisms in anti‐cancer actions of bioactive food components – the implications in cancer prevention
2012
Role of tissue stroma in cancer cell invasion
2003
Young-onset colorectal cancer
2023
ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes
2015
The cancer genome
2009 StandoutNature
Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome
2011
A Prospective, Multicenter, Population-Based Study of BRAF Mutational Analysis for Lynch Syndrome Screening
2007
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
Molecular Testing in Colorectal Cancer
2012
Hepatocellular Carcinoma
2019 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Hereditary gynaecological malignancies: advances in screening and treatment
2012
Clinical Relevance of Microsatellite Instability in Colorectal Cancer
2010
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
2011
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
2012
Practical genetics of colorectal cancer.
2013
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Hydrogels for Tissue Engineering
2001 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Stromal regulation of epithelial function
1991
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Disseminated Peritoneal Cancer of Gastrointestinal Origin
2000
Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients.
1991
Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline
2011
Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin
2001
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial
1993
Growth Factors and Cancer
1991 StandoutScience
Microsatellite instability in colorectal cancer
2006
Review article: overview of medical treatments in unresectable hepatocellular carcinoma—an impossible meta‐analysis?
1998
Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patients
1991
Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-? for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis
2000
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Adrenocortical Carcinoma
2013
Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma.
1991
Simple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
2015
Microsatellite Instability as a Biomarker for PD-1 Blockade
2016
Works of Mark Arnold being referenced
Modulation of Genetic and Epigenetic Biomarkers of Colorectal Cancer in Humans by Black Raspberries: A Phase I Pilot Study
2010
Concurrent sexual partnerships and racial disparities in HIV infection among men who have sex with men
2009
Pain, depression, and fatigue: Loneliness as a longitudinal risk factor.
2013
Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases
1996
Radioimmunoguided surgery for colorectal cancer
1996
Pilot Study Using a Humanized CC49 Monoclonal Antibody (HuCC49°CH2) to Localize Recurrent Colorectal Carcinoma
2004
Recombinant α2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial
1989
Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
2005
Squamous-cell carcinoma of the anal canal
1991
Intraoperative Detection of Colorectal Cancer With Radioimmunoguided Surgery and CC49, a Second-generation Monoclonal Antibody
1992
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes
2016
Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer
2001
Abdominal colon and rectal operations in the elderly
1991
Lymphoid activation by different crude alginates and the effect of purification.
1992
Expression of epithelial-like markers and class I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: orthotopic site effects.
1988
Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer.
1992
Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
2008